About
Francesca Domenech Wuttke is the Founder and CEO of Nen. She is a Managing Director focused on identifying new investment opportunities in Europe. Dr. Wuttke brings with her broad drug development and healthcare expertise in both the US and Europe, with over 20 years of clinical, commercial, strategic and transactional experience. She has worked with diverse organizations including start-ups, consulting. large and specialty pharma as well as academia. Most recently Dr. Wuttke led Almirall's Corporate Development Strategy team to transact on both med device and pharma M&A opportunities with a new and targeted focus for the company. Before that Dr. Wuttke worked at Novartis where she was responsible for the assessment and development of novel commercial models around two Cell and Gene therapy opportunities that were successfully brought into the organization as well as managing the strategy and commercialization for the existing portfolio of cell therapy assets. Prior to that Dr. Wuttke
Position in the VCSift Database
- • 1,349 investors hold the Founder and CEO role in VCSift. Francesca Domenech Wuttke is one of them.
- • 820 investors are based in Barcelona, Catalonia, Spain.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Barcelona, Spain
Contact Information
Find more investors like Francesca
Search Investors